Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Grandinetti

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|March 10, 2026
Lessons and Insights from a Case Study on Clinical Trial FraudCourtney McGuire, Jenn W Sellers, Cheryl Grandinetti, et al.
The New England Journal of Medicine|June 10, 2011
New FDA regulation to improve safety reporting in clinical trialsRachel Behrman Sherman, Janet Woodcock, Janet Norden, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug ApplicationPatrick Archdeacon, Cheryl Grandinetti, José M Vega, et al.
Therapeutic Innovation & Regulatory Science|April 30, 2026
Analyses of U.S. FDA GCP Assessments and Recommendations for Marketing Applications, 2015-2024Courtney McGuire, Michelle Foringer, David Burrow, et al.
Therapeutic Innovation & Regulatory Science|May 24, 2025
Keeping the End in Mind: Reviewing U.S. FDA Inspections of Submissions including Real-World DataCheryl Grandinetti, Donna R Rivera, Lee Pai-Scherf, et al.
Clinical Pharmacology and Therapeutics|November 6, 2025
Evolving Standards: Good Clinical Practice Insights from US FDA, MHRA UK, and Health CanadaCheryl Grandinetti, Mandy Budwal-Jagait, Hocine Abid, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice WorkshopNi A Khin, Gail Francis, Jean Mulinde, et al.
Clinical Pharmacology and Therapeutics|August 6, 2021
Tackling Challenging Data Integrity Topics in 2020: Update on Good Clinical Practice Perspectives from the US FDA and MHRA UKNi A Khin, Cheryl Grandinetti, Hayley Dixey, et al.
JAMA Network Open|June 17, 2025
Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health CollaborationDonna R Rivera, Tracy L Cutler, Lisa McShane, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|March 10, 2026
Lessons and Insights from a Case Study on Clinical Trial FraudCourtney McGuire, Jenn W Sellers, Cheryl Grandinetti, et al.
The New England Journal of Medicine|June 10, 2011
New FDA regulation to improve safety reporting in clinical trialsRachel Behrman Sherman, Janet Woodcock, Janet Norden, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug ApplicationPatrick Archdeacon, Cheryl Grandinetti, José M Vega, et al.
Therapeutic Innovation & Regulatory Science|April 30, 2026
Analyses of U.S. FDA GCP Assessments and Recommendations for Marketing Applications, 2015-2024Courtney McGuire, Michelle Foringer, David Burrow, et al.
Therapeutic Innovation & Regulatory Science|May 24, 2025
Keeping the End in Mind: Reviewing U.S. FDA Inspections of Submissions including Real-World DataCheryl Grandinetti, Donna R Rivera, Lee Pai-Scherf, et al.
Clinical Pharmacology and Therapeutics|November 6, 2025
Evolving Standards: Good Clinical Practice Insights from US FDA, MHRA UK, and Health CanadaCheryl Grandinetti, Mandy Budwal-Jagait, Hocine Abid, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice WorkshopNi A Khin, Gail Francis, Jean Mulinde, et al.
Clinical Pharmacology and Therapeutics|August 6, 2021
Tackling Challenging Data Integrity Topics in 2020: Update on Good Clinical Practice Perspectives from the US FDA and MHRA UKNi A Khin, Cheryl Grandinetti, Hayley Dixey, et al.
JAMA Network Open|June 17, 2025
Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health CollaborationDonna R Rivera, Tracy L Cutler, Lisa McShane, et al.
Pageof 1